Poster: Toxicity in silico antimalarial

Toxicity risks predictions and in silico structural-toxicity relationship evaluation of new amodiaquine analogues with antimalarial activity

Carlos Rangel Rodrigues, UFRJ



1 Nicolotti O, Benfenati E et al. REACH and in silico methods: an attractive opportunity for medicinal.
2 Brändén G, Sjögren T et al. Drug Disc Today, 19:7, 2014.
3 van de Waterbeemd H1, Gifford E. Nat Rev Drug Discov. 2:3, 2003.
4 Sun H, Scott D O et al. Biol. Drug Des. 75, 2010.
5 Villegas-Navarro A, Romero González M C, et al. Env Inter, 25:5, 1999.
6 Li XQ, Björkman A, Andersson TB et al. Eur J Clin Pharmacol 59:429–442, 2003.
7 Klaassen, C.D. In Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th edition. New York: McGraw-Hill, 2006.
8 Quilladert, P., Hofnung, M., Mutat. Res., 147: 65, 1985.
9 Maron, D.M., Ames, B.N., Mutat. Res., 113: 173, 1983.